Immutep SA - Crunchbase Company Profile & Funding

Q: Where is Immutep SA's headquarters?

Immutep SA is located in Saint-aubin, Franche-Comte, France.

Overview

Immutep SA

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Immutep SA

CB Rank

1476508

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

Acquired by

Immutep

Founded

obfuscation

Private

Saint-aubin, Franche-Comte, France

Biotechnology

Clinical Trials

Health Care

Oncology

Pharmaceutical

Details

Legal Name

Immutep S.A.

Operating Status

Closed

Company Type

For Profit

Founders

Frédéric Triebel

About the Company

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology. Their products include a T cell immunostimulatory factor (APC activator) for cancer chemo-immunotherapy and a therapeutic antibody for immune response modulation in cancer. The Company's technologies are based on the LAG-3 immune control mechanism which plays a

vital role in the regulation of the T cell immune response.

Phone Number

+33 (0) 160 123 250

Predictions & Insights

Products & Services

Eftilagimod Alpha (Efti)

A soluble LAG-3 protein and MHC Class II agonist designed to activate antigen-presenting cells, stimulating both innate and adaptive immunity for cancer treatment.

IMP761

A LAG-3 agonist antibody targeting activated T cells to suppress autoimmune responses by delivering a stronger inhibitory signal directly into the T cell.